Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 22 matching records.
22 results — page 1 of 1
- Level DAnimal StudyPubMed
Derivation of genetically stable mesenchymal stem cells from feline embryonic cell aggregates.
Animal Study on Scar, published in Vet J (2026) — summary generated from the PubMed abstract.
- 2026
Vet J - Level CProspective StudyPubMed
Human adipose-derived mesenchymal stromal cells in vitro expansion for regenerative applications: tracking small genetic variants reveals dynamic changes within a genetically stable framework.
Prospective Study on Osteoarthritis, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DAnimal StudyPubMed
Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis.
Animal Study on Osteoarthritis, Cartilage Damage, Neuroinflammation, Chronic Inflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction
Narrative Review on Cardiovascular Disease, Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther8 citations - Level DAnimal StudyEurope PMC
Mesenchymal Stem Cells Genetically Modified by Lentivirus-Express Soluble TRAIL and Interleukin-12 Inhibit Growth and Reduced Metastasis-Relate Changes in Lymphoma Mice Model
Animal Study, published in Biomedicines (2023) — summary generated from the PubMed abstract.
- 2023
Biomedicines6 citations - Level DLaboratory StudyEurope PMC
A Novel Drastic Peptide Genetically Adapted to Biomimetic Scaffolds "Delivers" Osteogenic Signals to Human Mesenchymal Stem Cells
Laboratory Study on Ankle & Foot, published in Nanomaterials (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Nanomaterials (Basel)1 citations - Level DNarrative ReviewEurope PMC
Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases
Narrative Review, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther7 citations - Level DLaboratory StudyPubMed
CUL4B orchestrates mesenchymal stem cell commitment by epigenetically repressing KLF4 and C/EBPδ.
Laboratory Study, published in Bone Res (2023) — summary generated from the PubMed abstract.
- 2023
Bone Res - Level DAnimal StudyEurope PMC
Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue
Animal Study on Chronic Inflammation, published in Nat Biomed Eng (2022) — summary generated from the PubMed abstract.
- 2022
Nat Biomed Eng96 citations - Level DAnimal StudyPubMed
Mesenchymal stem cells genetically engineered to express platelet-derived growth factor and heme oxygenase-1 ameliorate osteoarthritis in a canine model.
Animal Study with a reported sample of 4 on Osteoarthritis, Cartilage Damage, published in J Orthop Surg Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 4
J Orthop Surg Res - Level DLaboratory StudyPubMed
Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
Laboratory Study, published in Stem Cells (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cells - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Res Ther36 citations - Level DAnimal StudyPubMed
Genetically Engineered Adipose Mesenchymal Stem Cells Using HIV-Based Lentiviral Vectors as Gene Therapy for Autoimmune Diseases.
Animal Study on Immune Modulation, Autoimmune Research, published in Cell Reprogram (2018) — summary generated from the PubMed abstract.
- 2018
Cell Reprogram10 citations - Level DAnimal StudyPubMed
Sustained release of TGF-β1 via genetically-modified cells induces the chondrogenic differentiation of mesenchymal stem cells encapsulated in alginate sulfate hydrogels.
Animal Study, published in J Mater Sci Mater Med (2018) — summary generated from the PubMed abstract.
- 2018
J Mater Sci Mater Med - Level DLaboratory StudyPubMed
The Human IL-23 Decoy Receptor Inhibits T-Cells Producing IL-17 by Genetically Engineered Mesenchymal Stem Cells.
Laboratory Study on Immune Modulation, Autoimmune Research, published in Int J Cell Biol (2018) — summary generated from the PubMed abstract.
- 2018
Int J Cell Biol3 citations - Level BClinical TrialPubMed
Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma.
Clinical Trial on Systemic / IV, published in Stem Cells Dev (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Dev - Level DAnimal StudyPubMed
Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells.
Animal Study, published in Stem Cells Dev (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Dev - Level DAnimal StudyPubMed
Implant Composed of Demineralized Bone and Mesenchymal Stem Cells Genetically Modified with AdBMP2/AdBMP7 for the Regeneration of Bone Fractures in Ovis aries .
Animal Study, published in Stem Cells Int (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Int11 citations - Level DAnimal StudyPubMed
Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.
Animal Study on Systemic / IV, published in Immunol Invest (2015) — summary generated from the PubMed abstract.
- 2015
Immunol Invest12 citations - Level DNarrative ReviewPubMed
The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Rev Rep (2014) — summary generated from the PubMed abstract.
- 2014
Stem Cell Rev Rep19 citations - Level DAnimal StudyPubMed
Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice.
Animal Study, published in Exp Hematol (2011) — summary generated from the PubMed abstract.
- 2011
Exp Hematol - Level CProspective StudyPubMed
Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue.
Prospective Study on Chronic Wound, published in Tissue Eng (2005) — summary generated from the PubMed abstract.
- 2005
Tissue Eng250 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406